Asia-Pacific Uveitis Therapeutics Markets 2018-2023 – Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific uveitis market will be valued at $405.5m in 2023, growing from $179m in 2016, at a compound annual growth rate of 12.4%. It is a leading cause of blindness in both developed and developing countries and is the fifth most common cause of v